Disease management

Technological innovation has the power and promise to transform healthcare. This series spotlights companies developing such cutting-edge innovations—ranging from brain-computer and muscle-machine interfaces to 3D-printed breast bioprostheses and beyond.

The wristband is designed to alleviate essential tremors by modulating the nervous system and restoring motor control.

Also, new mobile applications promoting mental wellbeing have been launched.

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

The funds will be used to increase the company's research and development initiatives and expand its workforce. 

The company will use the funds to speed up the commercialization of BiWaze Clear, scale U.S. sales initiatives, invest in clinical research and increase patient participation.

Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.

Trained on two million skin images, it can perform a range of clinical tasks unlike current models.

Personify’s Transform Weight Management program will provide LucyRx members with personalized, coach-led guidance, incentives and assets to help manage their weight and medication.  

The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.